Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J Staab

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Investigations of droloxifene and other hormonal manipulations on N-nitrosomethylurea-induced rat mammary tumours. 2. Influence on oestrogen receptorM Görlich, G Winterfeld, P Hauff, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Investigations of droloxifene and other hormone manipulations on N-nitrosomethylurea-induced rat mammary tumours. 1. Influence on tumour growthG Winterfeld, P Hauff, M Görlich, et al.
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|June 1, 1981
Comparison of serum beta 2-microglobulin and carcinoembryonic antigen (CEA) in the follow-up of breast cancer patientsH J Staab, L M Ahlemann, F A Anderer, et al.
Acta Psychiatrica Scandinavica|April 1, 1997
Dose escalation vs. continued doses of paroxetine and maprotiline: a prospective study in depressed out-patients with inadequate treatment responseO Benkert, A Szegedi, H Wetzel, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Clinical pharmacology of the hypocholesterolemic agent K 12.148 (lifibrol) in healthy volunteersH Hasibeder, H J Staab, K Seibel, et al.
American Journal of Surgery|February 1, 1985
Eighty-four potential second-look operations based on sequential carcinoembryonic antigen determinations and clinical investigations in patients with recurrent gastrointestinal cancerH J Staab, F A Anderer, E Stumpf, et al.
Cancer Detection and Prevention|January 1, 1985
Optimizing tumor markers in breast cancer: monitoring, prognosis, and therapy controlH J Staab, L M Ahlemann, F A Anderer, et al.
Journal of Surgical Oncology|April 1, 1985
Prognostic value of preoperative serum CEA level compared to clinical staging: III. An approach to scoring of prognostic factors in colorectal cancerT Brümmendorf, F A Anderer, H J Staab, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1985
Differentiation of disease recurrence in various primary malignancies using CEA slope analysisH J Staab, T Brümmendorf, F A Anderer, et al.
Biochemical and Biophysical Research Communications|April 16, 1985
Monoclonal antibody-defined circulating human tumor-associated antigen with epitope shared by cytokeratinsM Hollmann, H J Staab, E Spindler, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Investigations of droloxifene and other hormonal manipulations on N-nitrosomethylurea-induced rat mammary tumours. 2. Influence on oestrogen receptorM Görlich, G Winterfeld, P Hauff, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Investigations of droloxifene and other hormone manipulations on N-nitrosomethylurea-induced rat mammary tumours. 1. Influence on tumour growthG Winterfeld, P Hauff, M Görlich, et al.
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|June 1, 1981
Comparison of serum beta 2-microglobulin and carcinoembryonic antigen (CEA) in the follow-up of breast cancer patientsH J Staab, L M Ahlemann, F A Anderer, et al.
Acta Psychiatrica Scandinavica|April 1, 1997
Dose escalation vs. continued doses of paroxetine and maprotiline: a prospective study in depressed out-patients with inadequate treatment responseO Benkert, A Szegedi, H Wetzel, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Clinical pharmacology of the hypocholesterolemic agent K 12.148 (lifibrol) in healthy volunteersH Hasibeder, H J Staab, K Seibel, et al.
American Journal of Surgery|February 1, 1985
Eighty-four potential second-look operations based on sequential carcinoembryonic antigen determinations and clinical investigations in patients with recurrent gastrointestinal cancerH J Staab, F A Anderer, E Stumpf, et al.
Cancer Detection and Prevention|January 1, 1985
Optimizing tumor markers in breast cancer: monitoring, prognosis, and therapy controlH J Staab, L M Ahlemann, F A Anderer, et al.
Journal of Surgical Oncology|April 1, 1985
Prognostic value of preoperative serum CEA level compared to clinical staging: III. An approach to scoring of prognostic factors in colorectal cancerT Brümmendorf, F A Anderer, H J Staab, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1985
Differentiation of disease recurrence in various primary malignancies using CEA slope analysisH J Staab, T Brümmendorf, F A Anderer, et al.
Biochemical and Biophysical Research Communications|April 16, 1985
Monoclonal antibody-defined circulating human tumor-associated antigen with epitope shared by cytokeratinsM Hollmann, H J Staab, E Spindler, et al.
Pageof 5